HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dong-Hyeon Kim Selected Research

Ulcerative Colitis

6/2022Comparative efficacy and safety of infliximab and vedolizumab therapy in patients with inflammatory bowel disease: a systematic review and meta-analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dong-Hyeon Kim Research Topics

Disease

4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022 - 01/2022
3COVID-19
06/2022 - 01/2022
3Rheumatic Diseases (Rheumatism)
06/2022 - 01/2022
3Body Weight (Weight, Body)
11/2017 - 01/2016
3Inflammation (Inflammations)
01/2016 - 01/2008
2Rheumatoid Arthritis
06/2022 - 01/2022
2Hemolysis
01/2022 - 06/2015
2Obesity
11/2017 - 01/2017
2Weight Gain
01/2016 - 02/2015
2Neoplasms (Cancer)
06/2008 - 01/2003
1Infections
06/2022
1Ulcerative Colitis
06/2022
1Crohn Disease (Crohn's Disease)
06/2022
1Cross Infection (Nosocomial Infection)
01/2022
1Diarrhea
04/2021
1Foodborne Diseases
08/2020
1Vibrio Infections
01/2020
1Constipation
01/2019
1Non-alcoholic Fatty Liver Disease
01/2017
1Peroneal Neuropathies
01/2017
1Melanoma (Melanoma, Malignant)
01/2016
1Insulin Resistance
01/2016
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
06/2015
1Respiratory Hypersensitivity
02/2008
1Pneumonia (Pneumonitis)
02/2008
1Asthma (Bronchial Asthma)
12/2004

Drug/Important Bio-Agent (IBA)

4Infliximab (Remicade)FDA Link
06/2022 - 01/2022
4CholesterolIBA
01/2019 - 02/2015
4alpha-galactosylceramideIBA
06/2008 - 12/2004
2Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 01/2020
2LDL CholesterolIBA
11/2017 - 01/2016
2Triglycerides (Triacylglycerol)IBA
11/2017 - 01/2016
2Fatty Acids (Saturated Fatty Acids)IBA
01/2017 - 01/2016
2AntigensIBA
06/2008 - 12/2004
2LigandsIBA
02/2008 - 12/2004
1vedolizumabIBA
06/2022
1Pharmaceutical PreparationsIBA
06/2022
1GelatinasesIBA
01/2022
1GelatinIBA
01/2022
1Enterotoxins (Enterotoxin)IBA
08/2020
1VLDL CholesterolIBA
11/2017
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1microcrystalline celluloseIBA
01/2016
1Bile Acids and Salts (Bile Acids)IBA
01/2016
1CeramidesIBA
01/2016
1FlavonoidsIBA
01/2016
1Insulin (Novolin)FDA Link
01/2016
1LipidsIBA
01/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2016
1ferric oxide (iron oxide)IBA
01/2016
1salicinIBA
06/2015
1EmeticsIBA
06/2015
1Phospholipases (Phospholipase)IBA
06/2015
1Starch (Cornstarch)IBA
06/2015
1VaccinesIBA
06/2008
1Cancer VaccinesIBA
06/2008
1Therapeutic UsesIBA
06/2008
1Interleukin-17 (Interleukin 17)IBA
01/2008
1AllergensIBA
12/2004
1OvalbuminIBA
12/2004
1DNA (Deoxyribonucleic Acid)IBA
01/2003
1AntibodiesIBA
01/2003

Therapy/Procedure

4Therapeutics
06/2022 - 01/2003
1Orthotic Devices (Orthosis)
01/2017
1Intranasal Administration
02/2008